17. The primary physiologic inhibitor of plasmin in-vivo is __________.

22. The APTT-based screening test for APC-R involves:

6. The __________ complex rapidly converts protein C to its activated state, resulting in proteolytic cleavage of activated factor V.

39. Blood component replacement therapy in DIC includes transfusion of:

13. What is the most widely accepted treatment used in hemophilia A?

45. Anti-factor VIII antibodies (inhibitors) may arise:

45. Anti-factor VIII antibodies (inhibitors) may arise:

27. Which laboratory tests are abnormal in DIC?

26. What is the normal range of fibrinogen in plasma?

38. Which laboratory test is prolonged in a factor XII deficiency?